Nivolumab vs Valsartan
Nivolumab vs Valsartan: Overview
This comparison examines the pharmacological differences between Nivolumab and Valsartan.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Valsartan: Angiotensin II type 1 receptor blocker.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Valsartan β 6 hours.
Chemical Properties
Molecular Formula: Valsartan β C24H29N5O3.
Molecular Weight: Valsartan β 435.5190 g/mol.
Type: Nivolumab β Antibody; Valsartan β Small molecule.